Shashank Ramesh Sirsi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shashank Ramesh Sirsi has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Sonia L. Hernandez
Department of Biomedical Engineering, University of Texas at Dallas, Richardson, TX, USA
4 shared publications Aditi Bellary
Department of Biomedical Engineering, University of Texas at Dallas, Richardson, TX, USA
3 shared publications- Baowei Fei
University of Texas at Dallas, Center for Imaging and Surgical Innovation, Richardson, Texas, United States
3 shared publications Ghazal Rastegar
Department of Bioengineering, University of Texas at Dallas
3 shared publications- Ghazal Rastegar
Department of Bioengineering, Erik Johnson School of Engineering, The University of Texas at Dallas, Richardson, TX 75080, USA
3 shared publications - Arvin Honari
Department of Bioengineering, Erik Johnson School of Engineering, The University of Texas at Dallas, Richardson, TX 75080, USA
2 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 703
Stabilized phospholipid-topotecan prodrug particles increase vascular permeability and ultrasound-enhanced neuroblastoma delivery
- 6 August 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 703
Open AccessStabilized phospholipid-topotecan prodrug particles increase vascular permeability and ultrasound-enhanced neuroblastoma delivery
- Open Access
- 12 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1743853
In vitro evaluation of PEI-coated microbubble– neutrophil conjugates for ultrasound-guided cell delivery
Background: Immunotherapies have advanced cancer treatment; however, their clinical efficacy remains limited for solid tumors due to challenges associated with effectively directing immune cells into the complex tumor microenvironment. Recent developments in Ultrasound Contrast Agent (UCA — also known as “microbubble”) technology have provided novel opportunities to enhance targeted therapeutic delivery. In this study, we introduce an innovative approach of leveraging microbubbles to enhance immune cell targeting by directly attaching microbubbles to immune cells, establishing an in vitro platform to evaluate microbubble–immune cell conjugation with potential applicability to ultrasound-guided delivery strategies. Methods: To create novel microbubble-immune cell conjugates, we created polyethyleneimine (PEI) coated microbubbles and attached them to differentiated HL-60 (dHL-60) cells. These positively charged PEI microbubbles were formulated using azide- DBCO click chemistry between DBCO-labeled microbubbles and the azide functional groups on the PEI polymer. Following this step, we utilized electrostatic interactions to attach our positively charged PEI microbubbles to our negatively charged dHL-60 cells. We conducted viability experiments to assess the compatibility of these designs and then used microfluidic chemotaxis platforms to quantify the microbubble-conjugated dHL-60 cell migratory behavior, examining parameters including migration velocity and percentage. Additionally, we investigated the impact of ultrasound power on primary human neutrophils to validate the functional responsiveness of these physiologically relevant immune cells. Results: We formulated our PEI microbubble-conjugated dHL-60 cells and verified that cell viability remained greater than 88% four hours after the conjugation process for different ratios of dHL-60 cells to PEI microbubbles. We found that cell: microbubble ratios of 1:1 and 1:2 produced higher migration rates compared to ratios of 1:5 and 1:10 for both dHL-60 cells and PEI microbubble-conjugated dHL-60 cells. Moreover, we found that higher microbubble binding also reduces cell velocity. Lastly, we found that cell migration remained comparable towards both chemoattractants under all ultrasound conditions tested (negative control, -30 dB, -10 dB, 0 dB) . Conclusions: Here we demonstrated the feasibility of ultrasound-compatible immune cell constructs while preserving migratory function in vitro . The novel PEI microbubble and immune cell conjugates reported in this work provide a foundation for future studies aimed at radiation-force-assisted immune cell delivery.
- 12 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1743853
Open AccessIn vitro evaluation of PEI-coated microbubble– neutrophil conjugates for ultrasound-guided cell delivery
Background: Immunotherapies have advanced cancer treatment; however, their clinical efficacy remains limited for solid tumors due to challenges associated with effectively directing immune cells into the complex tumor microenvironment. Recent developments in Ultrasound Contrast Agent (UCA — also known as “microbubble”) technology have provided novel opportunities to enhance targeted therapeutic delivery. In this study, we introduce an innovative approach of leveraging microbubbles to enhance immune cell targeting by directly attaching microbubbles to immune cells, establishing an in vitro platform to evaluate microbubble–immune cell conjugation with potential applicability to ultrasound-guided delivery strategies. Methods: To create novel microbubble-immune cell conjugates, we created polyethyleneimine (PEI) coated microbubbles and attached them to differentiated HL-60 (dHL-60) cells. These positively charged PEI microbubbles were formulated using azide- DBCO click chemistry between DBCO-labeled microbubbles and the azide functional groups on the PEI polymer. Following this step, we utilized electrostatic interactions to attach our positively charged PEI microbubbles to our negatively charged dHL-60 cells. We conducted viability experiments to assess the compatibility of these designs and then used microfluidic chemotaxis platforms to quantify the microbubble-conjugated dHL-60 cell migratory behavior, examining parameters including migration velocity and percentage. Additionally, we investigated the impact of ultrasound power on primary human neutrophils to validate the functional responsiveness of these physiologically relevant immune cells. Results: We formulated our PEI microbubble-conjugated dHL-60 cells and verified that cell viability remained greater than 88% four hours after the conjugation process for different ratios of dHL-60 cells to PEI microbubbles. We found that cell: microbubble ratios of 1:1 and 1:2 produced higher migration rates compared to ratios of 1:5 and 1:10 for both dHL-60 cells and PEI microbubble-conjugated dHL-60 cells. Moreover, we found that higher microbubble binding also reduces cell velocity. Lastly, we found that cell migration remained comparable towards both chemoattractants under all ultrasound conditions tested (negative control, -30 dB, -10 dB, 0 dB) . Conclusions: Here we demonstrated the feasibility of ultrasound-compatible immune cell constructs while preserving migratory function in vitro . The novel PEI microbubble and immune cell conjugates reported in this work provide a foundation for future studies aimed at radiation-force-assisted immune cell delivery.
- Open Access
- 1 July 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 12 (04) , 047001-13
Harnessing chemically crosslinked microbubble clusters using deep learning for ultrasound contrast imaging
Contrast-enhanced ultrasound (CEUS) imaging is a cost-effective and portable imaging modality that combines ultrasound imaging with microbubble-based ultrasound contrast agents (UCAs). These microbubbles (MBs), encapsulated in shells of lipid, protein, or polymer,1 act as vascular contrast agents circulating in the blood pool. With a compressible gas core, UCAs efficiently scatter ultrasound energy, inducing volumetric oscillations in response to an ultrasound field. This dynamic behavior enhances ultrasound image contrast.2 – 5 The unique acoustic characteristics of scattered echoes from MBs can be distinguished from surrounding tissues using harmonic and subharmonic frequency response,6,7 or nonlinear pulsing sequences,8 thereby improving the signal-to-noise ratio (SNR) and overall image contrast.6,9 – 11
- 1 July 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 12 (04) , 047001-13
Open AccessHarnessing chemically crosslinked microbubble clusters using deep learning for ultrasound contrast imaging
Contrast-enhanced ultrasound (CEUS) imaging is a cost-effective and portable imaging modality that combines ultrasound imaging with microbubble-based ultrasound contrast agents (UCAs). These microbubbles (MBs), encapsulated in shells of lipid, protein, or polymer,1 act as vascular contrast agents circulating in the blood pool. With a compressible gas core, UCAs efficiently scatter ultrasound energy, inducing volumetric oscillations in response to an ultrasound field. This dynamic behavior enhances ultrasound image contrast.2 – 5 The unique acoustic characteristics of scattered echoes from MBs can be distinguished from surrounding tissues using harmonic and subharmonic frequency response,6,7 or nonlinear pulsing sequences,8 thereby improving the signal-to-noise ratio (SNR) and overall image contrast.6,9 – 11
- 25 March 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 675, 125521
Oxygen Sensitive Drug Release Using Hemoglobin Microbubbles: A New Approach to Targeting Hypoxia in Ultrasound-Mediated Drug Delivery
- 25 March 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 675, 125521
Oxygen Sensitive Drug Release Using Hemoglobin Microbubbles: A New Approach to Targeting Hypoxia in Ultrasound-Mediated Drug Delivery
- 11 December 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 193, 305-315
Development of hemoglobin microbubbles for acoustic blood oxygen sensing: A study on PEGylation and gas core modification for in vivo applications
- 11 December 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 193, 305-315
Development of hemoglobin microbubbles for acoustic blood oxygen sensing: A study on PEGylation and gas core modification for in vivo applications
- 24 May 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (6) , 2826-2835
Development and Characterization of Hemoglobin Microbubbles for Acoustic Blood Oxygen Level Dependent Imaging
Oxygen levels in tissues and organs are crucial for their normal functioning, and approaches to monitor them non-invasively have wide biological and clinical applications. In this study, we developed a method of acoustically detecting oxygenation using contrast-enhanced ultrasound (CEUS) imaging. Our approach involved the use of specially designed hemoglobin-based microbubbles (HbMBs) that reversibly bind to oxygen and alter the state-dependent acoustic response. We confirmed that the bioactivity of hemoglobin remained intact after the microbubble shell was formed, and we did not observe any significant loss of heme. We conducted passive cavitation detection (PCD) experiments to confirm whether the acoustic properties of HbMBs vary based on the level of oxygen present. The experiments involved driving the HbMBs with a 1.1 MHz focused ultrasound transducer. Through the PCD data collected, we observed significant differences in the subharmonic and harmonic responses of the HbMBs when exposed to an oxygen-rich environment versus an oxygen-depleted one. We used a programmable ultrasound system to capture high-frame rate B mode videos of HbMBs in both oxy and deoxy conditions at the same time in a two-chambered flow phantom and observed that the mean pixel intensity of deoxygenated HbMB was greater than in the oxygenated state using B-mode imaging. Finally, we demonstrated that HbMBs can circulate in vivo and are detectable by a clinical ultrasound scanner. To summarize, our results indicate that CEUS imaging with HbMB has the potential to detect changes in tissue oxygenation and could be a valuable tool for clinical purposes in monitoring regional blood oxygen levels.
- 24 May 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (6) , 2826-2835
Development and Characterization of Hemoglobin Microbubbles for Acoustic Blood Oxygen Level Dependent Imaging
Oxygen levels in tissues and organs are crucial for their normal functioning, and approaches to monitor them non-invasively have wide biological and clinical applications. In this study, we developed a method of acoustically detecting oxygenation using contrast-enhanced ultrasound (CEUS) imaging. Our approach involved the use of specially designed hemoglobin-based microbubbles (HbMBs) that reversibly bind to oxygen and alter the state-dependent acoustic response. We confirmed that the bioactivity of hemoglobin remained intact after the microbubble shell was formed, and we did not observe any significant loss of heme. We conducted passive cavitation detection (PCD) experiments to confirm whether the acoustic properties of HbMBs vary based on the level of oxygen present. The experiments involved driving the HbMBs with a 1.1 MHz focused ultrasound transducer. Through the PCD data collected, we observed significant differences in the subharmonic and harmonic responses of the HbMBs when exposed to an oxygen-rich environment versus an oxygen-depleted one. We used a programmable ultrasound system to capture high-frame rate B mode videos of HbMBs in both oxy and deoxy conditions at the same time in a two-chambered flow phantom and observed that the mean pixel intensity of deoxygenated HbMB was greater than in the oxygenated state using B-mode imaging. Finally, we demonstrated that HbMBs can circulate in vivo and are detectable by a clinical ultrasound scanner. To summarize, our results indicate that CEUS imaging with HbMB has the potential to detect changes in tissue oxygenation and could be a valuable tool for clinical purposes in monitoring regional blood oxygen levels.
- Open Access
- 28 October 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (11) , 2550
Remote Loading: The Missing Piece for Achieving High Drug Payload and Rapid Release in Polymeric Microbubbles
The use of drug-loaded microbubbles for targeted drug delivery, particularly in cancer treatment, has been extensively studied in recent years. However, the loading capacity of microbubbles has been limited due to their surface area. Typically, drug molecules are loaded on or within the shell, or drug-loaded nanoparticles are coated on the surfaces of microbubbles. To address this significant limitation, we have introduced a novel approach. For the first time, we employed a transmembrane ammonium sulfate and pH gradient to load doxorubicin in a crystallized form in the core of polymeric microcapsules. Subsequently, we created remotely loaded microbubbles (RLMBs) through the sublimation of the liquid core of the microcapsules. Remotely loaded microcapsules exhibited an 18-fold increase in drug payload compared with physically loaded microcapsules. Furthermore, we investigated the drug release of RLMBs when exposed to an ultrasound field. After 120 s, an impressive 82.4 ± 5.5% of the loaded doxorubicin was released, demonstrating the remarkable capability of remotely loaded microbubbles for on-demand drug release. This study is the first to report such microbubbles that enable rapid drug release from the core. This innovative technique holds great promise in enhancing drug loading capacity and advancing targeted drug delivery.
- 28 October 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (11) , 2550
Open AccessRemote Loading: The Missing Piece for Achieving High Drug Payload and Rapid Release in Polymeric Microbubbles
The use of drug-loaded microbubbles for targeted drug delivery, particularly in cancer treatment, has been extensively studied in recent years. However, the loading capacity of microbubbles has been limited due to their surface area. Typically, drug molecules are loaded on or within the shell, or drug-loaded nanoparticles are coated on the surfaces of microbubbles. To address this significant limitation, we have introduced a novel approach. For the first time, we employed a transmembrane ammonium sulfate and pH gradient to load doxorubicin in a crystallized form in the core of polymeric microcapsules. Subsequently, we created remotely loaded microbubbles (RLMBs) through the sublimation of the liquid core of the microcapsules. Remotely loaded microcapsules exhibited an 18-fold increase in drug payload compared with physically loaded microcapsules. Furthermore, we investigated the drug release of RLMBs when exposed to an ultrasound field. After 120 s, an impressive 82.4 ± 5.5% of the loaded doxorubicin was released, demonstrating the remarkable capability of remotely loaded microbubbles for on-demand drug release. This study is the first to report such microbubbles that enable rapid drug release from the core. This innovative technique holds great promise in enhancing drug loading capacity and advancing targeted drug delivery.
- Open Access
- 26 August 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (9) , 2207
Cavitation-Enhanced Drug Delivery and Immunotherapy
Welcome to this special issue on Cavitation-Enhanced Drug Delivery and Immunotherapy—a rapidly evolving area that has been buoyed in recent years by the development of methods harnessing the activity of ultrasound-stimulated bubbles known as cavitation
- 26 August 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (9) , 2207
Open AccessCavitation-Enhanced Drug Delivery and Immunotherapy
Welcome to this special issue on Cavitation-Enhanced Drug Delivery and Immunotherapy—a rapidly evolving area that has been buoyed in recent years by the development of methods harnessing the activity of ultrasound-stimulated bubbles known as cavitation
- Open Access
- 17 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle
The estrogen receptor (ER) designated ERα has actions in many cell and tissue types that impact glucose homeostasis. It is unknown if these include mechanisms in endothelial cells, which have the potential to influence relative obesity, and processes in adipose tissue and skeletal muscle that impact glucose control. Here we show that independent of impact on events in adipose tissue, endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle. Endothelial ERα-deficient male mice are glucose intolerant and insulin resistant, and in females the antidiabetogenic actions of estradiol (E2) are absent. The glucose dysregulation is due to impaired skeletal muscle glucose disposal that results from attenuated muscle insulin delivery. Endothelial ERα activation stimulates insulin transcytosis by skeletal muscle microvascular endothelial cells. Mechanistically this involves nuclear ERα-dependent upregulation of vesicular trafficking regulator sorting nexin 5 (SNX5) expression, and PI3 kinase activation that drives plasma membrane recruitment of SNX5. Thus, coupled nuclear and non-nuclear actions of ERα promote endothelial insulin transport to skeletal muscle to foster normal glucose homeostasis.
- 17 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessEndothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle
The estrogen receptor (ER) designated ERα has actions in many cell and tissue types that impact glucose homeostasis. It is unknown if these include mechanisms in endothelial cells, which have the potential to influence relative obesity, and processes in adipose tissue and skeletal muscle that impact glucose control. Here we show that independent of impact on events in adipose tissue, endothelial ERα promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle. Endothelial ERα-deficient male mice are glucose intolerant and insulin resistant, and in females the antidiabetogenic actions of estradiol (E2) are absent. The glucose dysregulation is due to impaired skeletal muscle glucose disposal that results from attenuated muscle insulin delivery. Endothelial ERα activation stimulates insulin transcytosis by skeletal muscle microvascular endothelial cells. Mechanistically this involves nuclear ERα-dependent upregulation of vesicular trafficking regulator sorting nexin 5 (SNX5) expression, and PI3 kinase activation that drives plasma membrane recruitment of SNX5. Thus, coupled nuclear and non-nuclear actions of ERα promote endothelial insulin transport to skeletal muscle to foster normal glucose homeostasis.
- Open Access
- 10 June 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (6) , 1705
The Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation
Despite recent advancements in ultrasound-mediated drug delivery and the remarkable success observed in pre-clinical studies, no delivery platform utilizing ultrasound contrast agents has yet received FDA approval. The sonoporation effect was a game-changing discovery with a promising future in clinical settings. Various clinical trials are underway to assess sonoporation’s efficacy in treating solid tumors; however, there are disagreements on its applicability to the broader population due to long-term safety issues. In this review, we first discuss how acoustic targeting of drugs gained importance in cancer pharmaceutics. Then, we discuss ultrasound-targeting strategies that have been less explored yet hold a promising future. We aim to shed light on recent innovations in ultrasound-based drug delivery including newer designs of ultrasound-sensitive particles specifically tailored for pharmaceutical usage.
- 10 June 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (6) , 1705
Open AccessThe Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation
Despite recent advancements in ultrasound-mediated drug delivery and the remarkable success observed in pre-clinical studies, no delivery platform utilizing ultrasound contrast agents has yet received FDA approval. The sonoporation effect was a game-changing discovery with a promising future in clinical settings. Various clinical trials are underway to assess sonoporation’s efficacy in treating solid tumors; however, there are disagreements on its applicability to the broader population due to long-term safety issues. In this review, we first discuss how acoustic targeting of drugs gained importance in cancer pharmaceutics. Then, we discuss ultrasound-targeting strategies that have been less explored yet hold a promising future. We aim to shed light on recent innovations in ultrasound-based drug delivery including newer designs of ultrasound-sensitive particles specifically tailored for pharmaceutical usage.